Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:37:52.760Z.
Calculation as of: 2026-10-06T16:37:52.760Z.
Quote observation: 2026-10-06T16:34:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236
EARNINGS YIELD
N/A
Market Cap
$49.98M
Earnings Yield
N/A
TTM Avg
14.92%
3Y Avg
14.92%
5Y Avg
14.92%
Market Cap
$47.83M
Earnings Yield
N/A
TTM Avg
2.32%
3Y Avg
1.59%
5Y Avg
1.59%
Market Cap
$51.08M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $49.00M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $49.89M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $49.98M | N/A | 14.92% | 14.92% | 14.92% |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | N/A | 2.32% | 1.59% | 1.59% |
| Celularity Inc. (CELU)vs › | $50.37M | N/A | 11.78% | 11.68% | 11.68% |
| INmune Bio, Inc. (INMB)vs › | $50.51M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $51.05M | N/A | 8.45% | 8.45% | 8.45% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.08M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.61M | 9.97% | 27.99% | 16.26% | 33.61% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
